Brain Death

PROBLEM AND SOLUTION 

80% of the first stage of clinical trials fail, while our unique approach using subjects with brain death prevents this failure without a necessity to spend millions on trials.

KEY BENEFITS

Easier to determine dosage

Access to low-cost medical facilities overseas;

Saving lives of healthy people;

Completely legal and ethical.

Fast evaluation of drug efficiency and safety before clinical trials

LEGAL AND ETHICAL ASPECTS

 
The legal aspect is based on voluntary participation in the study, as well as the law that allows any adult to donate their organs/body for research and transplantation;
Long-term contracts with two clinical sites in Europe, all necessary licenses are present.